The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.

MLA

Takamiya, Rina, et al. “The Single N-Glycan Deletion Mutant of Soluble ErbB3 Protein Attenuates Heregulin Β1-Induced Tumor Progression by Blocking of the HIF-1 and Nrf2 Pathway.” Biochemical and Biophysical Research Communications, vol. 454, no. 3, Nov. 2014, pp. 364–68. EBSCOhost, https://doi.org/10.1016/j.bbrc.2014.10.086.

APA

Takamiya, R., Takahashi, M., Uehara, Y., Ariki, S., Hashimoto, J., Hasegawa, Y., & Kuroki, Y. (2014). The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway. Biochemical and Biophysical Research Communications, 454(3), 364–368. https://doi.org/10.1016/j.bbrc.2014.10.086

Chicago

Takamiya, Rina, Motoko Takahashi, Yasuaki Uehara, Shigeru Ariki, Jiro Hashimoto, Yoshihiro Hasegawa, and Yoshio Kuroki. 2014. “The Single N-Glycan Deletion Mutant of Soluble ErbB3 Protein Attenuates Heregulin Β1-Induced Tumor Progression by Blocking of the HIF-1 and Nrf2 Pathway.” Biochemical and Biophysical Research Communications 454 (3): 364–68. doi:10.1016/j.bbrc.2014.10.086.